African American Patients Unnecessarily Excluded From AML Clinical Trials
December 8th 2019Baseline laboratory values for AML clinical trials are setting unnecessary restrictions for kidney function that excludes African American patients with AML when this comorbidity does not impact overall survival.
Read More
Mosunetuzumab Produces Complete Remissions in Patients with Non-Hodgkin Lymphoma
December 8th 2019Some patients with non-Hodgkin lymphoma may soon have a treatment option that could offer complete remission, according to new data presented at the American Society of Hematology 2019 Annual Meeting.
Read More